Alix Démaris

Alix Démaris is an Associate Consultant at qPharmetra since April 2023, following completion of a PhD in March 2023 focused on optimizing monoclonal antibody therapy in inflammatory bowel disease through the PharMetrX Graduate Research Training Program. Previous experience includes internships at Sanofi, where Alix engaged in pharmacokinetic (PopPK and PBPK) modeling for early drug development and therapeutic dose determination. Alix also completed internships at Beaujon Hospital, Cochin Hospital, and various pharmacies, concentrating on pharmacokinetics and therapeutic drug monitoring. Alix's academic background includes multiple degrees from Université Paris Cité in fields such as statistics, modeling, pharmacokinetics, and pharmaceutical sciences, as well as a Bachelor's degree in Sciences from Fénelon Sainte-Marie High School.